Dr Adriana Sanna is a molecular and translational oncologist with a primary focus on melanoma biology. Originally from Sardinia, Italy, she has pursued a highly international scientific career across leading European and U.S. research institutions. Her training began at the IFOM–IEO campus of the University of Milan and continued at Leiden University Medical Center, where she specialised in Biomedical Sciences Research and conducted part of her work at the Norris Comprehensive Cancer Center, Keck School of Medicine of USC in Los Angeles. She subsequently received a competitive Marie Skłodowska-Curie Fellowship (Horizon 2020) within the MELanomaGENomics programme and completed her PhD in Biomedicine, Cancer and Molecular Biology at Lund University in 2020. Through this programme, she remains an active member of the international GenoMel consortium, contributing to collaborative genomic studies of melanoma. Dr Sanna then carried out postdoctoral research at the Spanish National Cancer Research Centre (CNIO) in Madrid, where she worked on mechanistic and translational aspects of melanoma. She is currently a postdoctoral fellow at the Paula Fox Melanoma and Cancer Center at Monash University in Melbourne, in the laboratory of Professor Shackleton, where her work integrates molecular, genomic, and functional approaches to interrogate melanoma heterogeneity and therapy resistance.